Law360, New York (January 22, 2010, 10:43 AM ET) -- Boston Scientific Corp. has prevailed in a consolidated suit against Johnson & Johnson Inc., now that a federal judge has found invalid four J&J patents for a drug-eluting stent.
The summary judgment ruling Wednesday by Judge Sue L. Robinson of the U.S. District Court for the District of Delaware halted a trial that was to begin in February.
In a memorandum opinion, Judge Robinson held that the disputed claims of the four patents — which J&J alleged were infringed by the Promus stent system produced by...
J&J Stent Patents Found Invalid In Boston Sci Suit
To view the full article, take a free trial now.
